Market news

Detailed price information for Definitive Healthcare Corp Cl A (DH-Q) from The Globe and Mail including charting and trades.

Definitive Healthcare Corp. (NASDAQ:DH) shares rose 13% on Wednesday after Advent International submitted a non-binding proposal to acquire shares and units it does not already own for $1.

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outst

Mr. Ritchey brings more than 25 years of deep healthcare expertise to DefinitiveFRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company’s next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026. Mr. Ritchey succeeds Kevin Coop, who departe

Definitive Healthcare (DH) said Wednesday it received a non-binding acquisition proposal from privat

Detailed price information for Definitive Healthcare Corp Cl A (DH-Q) from The Globe and Mail including charting and trades.

Detailed price information for Definitive Healthcare Corp Cl A (DH-Q) from The Globe and Mail including charting and trades.

Detailed price information for Ataibeckley Inc (ATAI-Q) from The Globe and Mail including charting and trades.

Definitive Healthcare (DH) has an average rating of hold and mean price target of $1.70, according t

Moby summary of Definitive Healthcare Corp.'s Q2 2026 earnings call

Definitive Healthcare (DH) has an average rating of hold and mean price target of $2.03, according t

Definitive Healthcare Corp (DH) navigates a 9% revenue dip while unveiling its Turbo AI platform and securing its strongest biopharma new business quarter in three years.

Motley Fool Press Release.

Second Quarter Revenue Within Guidance Range; Profit Surpasses ExpectationsFRAMINGHAM, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights: Revenue was $55.2 million, a decrease of 9% from $60.8 million in Q2 2025. Net Loss was $(7.5) million, or (14)% o

FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its second quarter ended June 30, 2026, on Monday, August 10, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event will be avail

Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Srinivas Attipalli of the Company, Definitive Healthcare’s new SVP and Head of AI & Data - Product, an induceme